GlassScriptPhysician profile
Anton J Koopman
NPI 1538182035
$4,486.33
in general payments reported to CMS, 2019-2025
43 companies · $848 in 2025
The $848 reported for 2025 was more than what 83% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $705 · 2020: $648 · 2021: $117 · 2022: $384 · 2023: $915 · 2024: $870 · 2025: $848.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,633.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,633.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,316.18 | 2019-2025 | Farxiga, Bevespi Aerosphere, Fasenra |
| Novo Nordisk INC | $401.47 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $398.10 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $383.70 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Abbvie INC. | $289.71 | 2021-2025 | |
| Otsuka America Pharmaceutical, INC. | $163.98 | 2022-2025 | Rexulti |
| Axsome Therapeutics, INC. | $153.14 | 2024-2025 | Auvelity |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $144.82 | 2019-2023 | Xifaxan |
| Abbott Laboratories | $103.30 | 2022-2025 | Freestyle Libre 3 |
| Welch Allyn | $96.25 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $86.28 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $82.87 | 2019-2023 | Trintellix |
| Exact Sciences Corporation | $68.37 | 2023-2025 | Cologuard Collection Kit |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $55.26 | 2022-2023 | |
| Pfizer INC. | $54.56 | 2019-2025 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anton Koopman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.